ATR INHIBITOR IN COMBINATION WITH OLAPARIB/ DURVALUMAB (MEDI4736) IN GYNAECOLOGICAL CANCERS WITH ARID1A LOSS OR NO LOSS

Registry ID

ATARI

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

PRINCESS MARGARET CANCER CENTRE

Start date

2022-03-31

Last update

2020-11-24

Conditions

• OVARIAN CARCINOMA

Related clinical trials

• A RANDOMIZED PHASE III, TWO-ARM TRIAL OF PACLITAXEL/CARBOPLATIN/MAINTENANCE LETROZOLE VERSUS LETROZOLE MONOTHERAPY IN PATIENTS WITH STAGE II-IV, PRIMARY LOW-GRADE SEROUS CARCINOMA OF THE OVARY OR PERITONEUM

View on source registry